Cubist Pharmaceuticals acquires Adolor - MarketLine Financial Deals

Cubist Pharmaceuticals acquires Adolor

Cubist Pharmaceuticals acquires Adolor - MarketLine Financial Deals
Cubist Pharmaceuticals acquires Adolor
Published Dec 12, 2011
10 pages — Published Dec 12, 2011
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Cubist Pharmaceuticals, Inc., a biopharmaceutical company, has acquired all of the outstanding shares of Adolor Corporation, a biotechnology company, for an aggregate upfront cash consideration of approximately $221 million.

  
Source:
Document ID
MA84710_111027
Country
Ticker
CBST=US
Ticker
ADLR=US
Company
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Cubist Pharmaceuticals acquires Adolor" Dec 12, 2011. Alacra Store. Dec 08, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Cubist-Pharmaceuticals-acquires-Adolor-2052-71470>
  
APA:
MarketLine Financial Deals. (2011). Cubist Pharmaceuticals acquires Adolor Dec 12, 2011. New York, NY: Alacra Store. Retrieved Dec 08, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Cubist-Pharmaceuticals-acquires-Adolor-2052-71470>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.